Stay updated with breaking news from Zymeworks Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cytovia Therapeutics, a Florida company with research-and-development operations in Natick, has named a chief financial officer and a chief product officer, as the company advances towards clinical trials and prepares to go public.
/PRNewswire/ -- Cytovia Therapeutics, LLC ("Cytovia Therapeutics"), a global biotechnology company focused on empowering natural killer (NK) cells to fight...
Shares of Zymeworks Inc. (NYSE:ZYME – Get Rating) have been given an average recommendation of “Buy” by the nine brokerages that are currently covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 12 month price objective among […]
Zymeworks (NYSE:ZYME – Get Rating) had its price target hoisted by equities researchers at SVB Leerink from $18.00 to $19.00 in a report released on Friday, Stock Target Advisor reports. The firm presently has an “outperform” rating on the stock. SVB Leerink’s price objective would suggest a potential upside of 198.27% from the stock’s current […]
Zymeworks Inc. , a clinical-stage biopharmaceutical company developing next-generation multifunctional biotherapeutics, today announced that management will participate in an upcoming investor... | May 27, 2022